Photo by Martin/pexels A groundbreaking study has brought new hope in the battle against multiple myeloma (MM), a challenging and often incurable blood cancer. Researchers have successfully activated T...
Photo by Chokniti Khongchum/pexels In a significant breakthrough for the treatment of cholangiocarcinoma (CCA), a highly lethal cancer of the bile duct epithelial cells, researchers have developed a novel...
Image by u_ys074yedl6/pixabay CAR T cell targeting T‐cell receptor β‐chain constant domains 1 (TRBC1) of malignant T cells has been developed using JOVI.1 monoclonal antibody as a template However,...
Photo by Chokniti Khongchum/pexels Cholangiocarcinoma (CCA), a form of liver cancer, has long posed challenges in treatment due to its genetic complexity. However, a recent study published in PeerJ has shed...
Photo by RF._.studio/pexels In a significant advancement for the treatment of B-cell malignancies, researchers have developed a new generation of chimeric antigen receptor (CAR) T cells with fully human-derived...
A groundbreaking study has delved into the potential interactions between cannabidiol (CBD) and CD19-chimeric antigen receptor (CAR) T cell therapy, a promising approach in cancer immunotherapy. The study aimed...